STRS Ohio’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-8,700
| Closed | -$45K | – | 2125 |
|
2024
Q1 | $45K | Sell |
8,700
-500
| -5% | -$2.59K | ﹤0.01% | 1774 |
|
2023
Q4 | $48K | Hold |
9,200
| – | – | ﹤0.01% | 1783 |
|
2023
Q3 | $145K | Buy |
+9,200
| New | +$145K | ﹤0.01% | 1649 |
|
2022
Q3 | – | Sell |
-2,900
| Closed | -$128K | – | 2117 |
|
2022
Q2 | $128K | Sell |
2,900
-6,400
| -69% | -$282K | ﹤0.01% | 1707 |
|
2022
Q1 | $460K | Buy |
+9,300
| New | +$460K | ﹤0.01% | 1472 |
|
2020
Q4 | – | Sell |
-1,600
| Closed | -$67K | – | 2308 |
|
2020
Q3 | $67K | Sell |
1,600
-10,600
| -87% | -$444K | ﹤0.01% | 1918 |
|
2020
Q2 | $585K | Buy |
12,200
+400
| +3% | +$19.2K | ﹤0.01% | 1195 |
|
2020
Q1 | $542K | Buy |
11,800
+400
| +4% | +$18.4K | ﹤0.01% | 1068 |
|
2019
Q4 | $684K | Sell |
11,400
-200
| -2% | -$12K | ﹤0.01% | 1200 |
|
2019
Q3 | $656K | Sell |
11,600
-800
| -6% | -$45.2K | ﹤0.01% | 1039 |
|
2019
Q2 | $690K | Buy |
12,400
+500
| +4% | +$27.8K | ﹤0.01% | 1026 |
|
2019
Q1 | $600K | Hold |
11,900
| – | – | ﹤0.01% | 1150 |
|
2018
Q4 | $479K | Hold |
11,900
| – | – | ﹤0.01% | 1270 |
|
2018
Q3 | $825K | Hold |
11,900
| – | – | ﹤0.01% | 994 |
|
2018
Q2 | $900K | Buy |
11,900
+9,900
| +495% | +$749K | ﹤0.01% | 958 |
|
2018
Q1 | $105K | Sell |
2,000
-400
| -17% | -$21K | ﹤0.01% | 1606 |
|
2017
Q4 | $128K | Sell |
2,400
-10,100
| -81% | -$539K | ﹤0.01% | 1573 |
|
2017
Q3 | $745K | Buy |
12,500
+3,200
| +34% | +$191K | ﹤0.01% | 1094 |
|
2017
Q2 | $733K | Buy |
9,300
+1,300
| +16% | +$102K | ﹤0.01% | 1049 |
|
2017
Q1 | $663K | Buy |
+8,000
| New | +$663K | ﹤0.01% | 1160 |
|
2016
Q2 | – | Sell |
-6,100
| Closed | -$247K | – | 2060 |
|
2016
Q1 | $247K | Sell |
6,100
-2,300
| -27% | -$93.1K | ﹤0.01% | 1462 |
|
2015
Q4 | $744K | Sell |
8,400
-1,400
| -14% | -$124K | ﹤0.01% | 987 |
|
2015
Q3 | $725K | Hold |
9,800
| – | – | ﹤0.01% | 1013 |
|
2015
Q2 | $792K | Buy |
+9,800
| New | +$792K | ﹤0.01% | 1035 |
|